BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
21 results:

  • 1. Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant prostate cancer (Alliance A031201 Trial).
    Morris MJ; Heller G; Hillman DW; Bobek O; Ryan C; Antonarakis ES; Bryce AH; Hahn O; Beltran H; Armstrong AJ; Schwartz L; Lewis LD; Beumer JH; Langevin B; McGary EC; Mehan PT; Goldkorn A; Roth BJ; Xiao H; Watt C; Taplin ME; Halabi S; Small EJ
    J Clin Oncol; 2023 Jun; 41(18):3352-3362. PubMed ID: 36996380
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced prostate Carcinoma.
    Vidal Crespo N; Enguita Arnal L; Gómez-Ferrer Á; Collado Serra A; Mascarós JM; Calatrava Fons A; Casanova Ramón-Borja J; Rubio Briones J; Ramírez-Backhaus M
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013525
    [No Abstract]    [Full Text] [Related]  

  • 3. Development of a 3D CNN-based AI Model for Automated Segmentation of the Prostatic Urethra.
    Belue MJ; Harmon SA; Patel K; Daryanani A; Yilmaz EC; Pinto PA; Wood BJ; Citrin DE; Choyke PL; Turkbey B
    Acad Radiol; 2022 Sep; 29(9):1404-1412. PubMed ID: 35183438
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant prostate cancer: Systematic Review and Meta-Analysis.
    Liu RJ; Hu Q; Li SY; Mao WP; Xu B; Chen M
    Technol Cancer Res Treat; 2021; 20():15330338211035260. PubMed ID: 34313171
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear data for reactor production of
    Kulage Z; Cantrell T; Griswold J; Denton D; Garland M; Copping R; Mirzadeh S
    Appl Radiat Isot; 2021 Jun; 172():109645. PubMed ID: 33689941
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized prostate cancer.
    Dee EC; Muralidhar V; Arega MA; Kishan AU; Spratt DE; Dess RT; King MT; Sha ST; Santos PMG; Butler SS; Sanford NN; Nguyen PL; Mahal BA
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1279-1285. PubMed ID: 33276019
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis.
    Metzger AL; Abel S; Wegner RE; Fuhrer R; Mao S; Miller R; Beriwal S; Horne ZD
    Prostate; 2019 Sep; 79(12):1457-1461. PubMed ID: 31294484
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extensive Histological Sampling following Focal Therapy of Clinically Significant prostate cancer with High Intensity Focused Ultrasound.
    Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
    J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings.
    Qian Z; Wang Y; Tang Z; Ren D; Wang Z; Chen W; Li Z
    J Med Econ; 2019 Aug; 22(8):728-735. PubMed ID: 30913930
    [No Abstract]    [Full Text] [Related]  

  • 10. Health inequities and cancer survival in Manizales, Colombia: a population-based study.
    Arias-Ortiz NE; de Vries E
    Colomb Med (Cali); 2018 Mar; 49(1):63-72. PubMed ID: 29983465
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Occurrence of Malnutrition and Associated Factors in Community-Dwelling Older Adults: Those with a Recent Diagnosis of cancer Are at Higher Risk.
    Van Den Broeke C; De Burghgraeve T; Ummels M; Gescher N; Deckx L; Tjan-Heijnen V; Buntinx F; van den Akker M
    J Nutr Health Aging; 2018; 22(2):191-198. PubMed ID: 29380845
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Oncological results in high grade prostate cancer treated surgically].
    Aguilera A; Alonso-Dorrego JM; Bañuelos B; Cisneros J; González P; Díez J
    Arch Esp Urol; 2016 May; 69(4):162-71. PubMed ID: 27225053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Korean prostate cancer patients have worse disease characteristics than their American counterparts.
    Kang DI; Chung JI; Ha HK; Min K; Yoon J; Kim W; Seo WI; Kang Pm; Jung SJ; Kim IY
    Asian Pac J Cancer Prev; 2013; 14(11):6913-7. PubMed ID: 24377625
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
    Rothwell PM; Fowkes FG; Belch JF; Ogawa H; Warlow CP; Meade TW
    Lancet; 2011 Jan; 377(9759):31-41. PubMed ID: 21144578
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
    Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
    Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.
    Ryan CW; Huo D; Stallings JW; Davis RL; Beer TM; McWhorter LT
    Urology; 2007 Jul; 70(1):122-6. PubMed ID: 17656221
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
    Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death.
    Alcantara P; Hanlon A; Buyyounouski MK; Horwitz EM; Pollack A
    Cancer; 2007 Jan; 109(1):41-7. PubMed ID: 17133416
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
    el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
    Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.